2m 2m 2m 2m 2m 2m 2m
PRELUDE THERAP (PRLD)
NASDAQ
$3.66$0.00 (0.00%)
Price as of Jun 03, 2026 7:01 PM EDT- $254.5MMarket Cap
- 274.21%1-Year Change
- BiotechnologyIndustry
PRELUDE THERAP (PRLD)
$3.66$0.00 (0.00%)
Top Holders
Institutional
Mutual Funds
Holder | Ownership %
| Shares Held | Change (Shares, %) | Report Date |
|---|---|---|---|---|
ORBIMED ADVISORS LLC | 13.90% | 10.9M | 0 (0.00%) | Mar 31, 2026 |
BAKER BROS. ADVISORS LP | 12.90% | 10.1M | 0 (0.00%) | Mar 31, 2026 |
BOXER CAPITAL, LLC | 2.18% | 1.7M | -860,100 (-50.35%) | Sep 30, 2024 |
KYNAM CAPITAL MANAGEMENT, LP | 2.03% | 1.6M | +803,684 (+50.47%) | Mar 31, 2026 |
VANGUARD GROUP INC | 1.80% | 1.4M | +421,132 (+29.78%) | Dec 31, 2025 |
N/A | 1.57% | 1.2M | +1.2M (+100.00%) | Mar 31, 2026 |
BLACKROCK FUNDING, INC. /DE | 1.36% | 1.1M | +11,457 (+1.07%) | Dec 31, 2024 |
Holder | Ownership %
| Shares Held | Change (Shares, %) | Report Date |
|---|---|---|---|---|
VANGUARD INDEX FUNDS | 1.53% | 1.2M | -22,138 (-1.85%) | Mar 31, 2026 |
FIDELITY ADVISOR SERIES VII | 1.36% | 1.1M | 0 (0.00%) | Jan 31, 2026 |
FIDELITY SECURITIES FUND | 1.14% | 894,468 | 0 (0.00%) | Jan 31, 2026 |
SPDR SERIES TRUST | 0.83% | 649,460 | 0 (0.00%) | Jan 31, 2026 |
T. Rowe Price Health Sciences Fund, Inc. | 0.66% | 516,220 | 0 (0.00%) | Mar 31, 2026 |
Fidelity Rutland Square Trust II | 0.56% | 442,180 | 0 (0.00%) | Feb 28, 2026 |
Federated Hermes Equity Funds | 0.43% | 336,100 | 0 (0.00%) | Jan 31, 2026 |
Current Ownership Distribution
- Institutions604.7M (84.28%)
- Mutual Funds77.7M (10.83%)
- Insiders35.1M (4.89%)
- Other0 (0.00%)
Insider Transactions
- 4.89% (35.1M)Current InsiderOwnership (%, shares)
- 0Number of InsiderBuying (last 12 months)
- $0.00Amount of InsiderBuying (last 12 months)
- 0Number of InsiderSelling (last 12 months)
- $0.00Amount of InsiderSelling (last 12 months)
Insider Name & Title | Type | Date
| Transaction Value | Shares | Share Price | Shares After Transactions |
|---|---|---|---|---|---|---|
RA CAPITAL MANAGEMENT, LLC | Other | Apr 27, 2026 | $0.00 | 1.4M | $0.00 | 1.4M |
RA CAPITAL MANAGEMENT, LLC | Other | Apr 27, 2026 | $0.00 | 1.4M | $0.00 | 6.5M |
Combs Andrew Chief Chemistry Officer | Award | Feb 04, 2026 | $0.00 | 230,000 | $0.00 | 230,000 |
Vaddi Krishna CEO | Award | Feb 04, 2026 | $0.00 | 837,000 | $0.00 | 837,000 |
Lim Bryant David CLO, CFO, Corp Sec. | Award | Feb 04, 2026 | $0.00 | 275,000 | $0.00 | 275,000 |
Sandor Victor | Award | Nov 05, 2025 | $0.00 | 121,285 | $0.00 | 121,285 |
Huang Jane President, CMO | Exempt | Jul 04, 2025 | $0.00 | 9,375 | $0.00 | 28,125 |
Huang Jane President, CMO | Exempt | Jul 04, 2025 | $0.00 | 9,375 | $0.00 | 84,252 |
Huang Jane President, CMO | In Kind | Jul 04, 2025 | $2,663.53 | 3,355 | $0.79 | 80,897 |
FRIEDMAN PAUL A | Award | Jun 12, 2025 | $0.00 | 38,000 | $0.00 | 38,000 |
BAKER BROS. ADVISORS LP | Award | Jun 12, 2025 | $0.00 | 76,000 | $0.00 | 76,000 |
Babler Martin | Award | Jun 12, 2025 | $0.00 | 38,000 | $0.00 | 38,000 |
BAKER BROS. ADVISORS LP | Award | Jun 12, 2025 | $0.00 | 76,000 | $0.00 | 76,000 |
Bonita David P | Award | Jun 12, 2025 | $0.00 | 38,000 | $0.00 | 38,000 |
Dier Mardi | Award | Jun 12, 2025 | $0.00 | 38,000 | $0.00 | 38,000 |
Huang Jane President, CMO | Exempt | Apr 04, 2025 | $0.00 | 9,375 | $0.00 | 37,500 |
Huang Jane President, CMO | Exempt | Apr 04, 2025 | $0.00 | 9,375 | $0.00 | 78,232 |
Huang Jane President, CMO | In Kind | Apr 04, 2025 | $2,264.63 | 3,355 | $0.68 | 74,877 |
Vaddi Krishna CEO | Buy | Mar 25, 2025 | $467,437.50 | 675,000 | $0.69 | 2.0M |
Combs Andrew Chief Chemistry Officer | Buy | Mar 25, 2025 | $69,250.00 | 100,000 | $0.69 | 480,123 |
Vaddi Krishna CEO | Buy | Mar 21, 2025 | $10,959.00 | 15,000 | $0.73 | 1.3M |
Vaddi Krishna CEO | Buy | Mar 20, 2025 | $3,950.43 | 5,416 | $0.73 | 1.3M |
Vaddi Krishna CEO | Buy | Mar 17, 2025 | $6,828.59 | 9,106 | $0.75 | 1.3M |
Vaddi Krishna CEO | Buy | Mar 14, 2025 | $22,631.25 | 29,999 | $0.75 | 1.3M |
Vaddi Krishna CEO | Buy | Mar 13, 2025 | $35,820.00 | 50,000 | $0.72 | 1.3M |
Vaddi Krishna CEO | Buy | Mar 12, 2025 | $33,744.00 | 47,500 | $0.71 | 1.2M |
Lim Bryant David CLO, CFO, Corp Sec. | Award | Feb 04, 2025 | $0.00 | 200,000 | $0.00 | 200,000 |
Vaddi Krishna CEO | Award | Feb 04, 2025 | $0.00 | 496,000 | $0.00 | 496,000 |
Huang Jane President, CMO | Award | Feb 04, 2025 | $0.00 | 200,000 | $0.00 | 200,000 |
Scherle Peggy Chief Scientific Officer | Award | Feb 04, 2025 | $0.00 | 175,000 | $0.00 | 175,000 |